Date: March 2007
Length: 00:19:24
Size: 8.88MB
Thought Leaders: Rob Rogers, Chief Creative Officer, Sudler & Hennessey, Bruno Stucchi, Global Creative Director, Sudler & Hennessey, Milan, Italy
In this Podcast episode, two advertising executives provide a creative twist as they discuss the next evolution in global pharmaceutical branding. They talk about new approaches to branding on a global scale, why brand managers should think about return on concept rather than return on investment, and ways in which the Internet is providing global marketing opportunities for brands of all sizes.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Monday, March 19, 2007
Tuesday, March 06, 2007
Leadership Development
Date: March 2007
Length: 00:15:54
Size: 7.28MB
Thought Leader: Jonathan E. Lim, M.D., President and CEO, Halozyme Therapeutics
A career in the life sciences can be extremely rewarding. Dr. Lim shares his views and practices for finding and developing talent. He also discusses the value of interpersonal skills, and the effects of globalization on the workforce.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:15:54
Size: 7.28MB
Thought Leader: Jonathan E. Lim, M.D., President and CEO, Halozyme Therapeutics
A career in the life sciences can be extremely rewarding. Dr. Lim shares his views and practices for finding and developing talent. He also discusses the value of interpersonal skills, and the effects of globalization on the workforce.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
EDC and After
Date: March 2007
Length: 00:18:14
Size: 8.34MB
Thought Leaders: Dr. Stephen Rhys Thomas, Senior Partner, and John F. Murray, Senior Partner, Procela Partners
Based on Procela Partners' comprehensive research into the EDC landscape, Dr. Thomas and Mr. Murray provide an independent, insiders' review of the latest trends in the EDC market, including a discussion related to convergent strategies for streamlining the adoption cycle for new technologies as well as the challenges vendors and sponsors face in implementing enterprisewide systems. They also provide a provocative preview of the e-clinical landscape after EDC.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:18:14
Size: 8.34MB
Thought Leaders: Dr. Stephen Rhys Thomas, Senior Partner, and John F. Murray, Senior Partner, Procela Partners
Based on Procela Partners' comprehensive research into the EDC landscape, Dr. Thomas and Mr. Murray provide an independent, insiders' review of the latest trends in the EDC market, including a discussion related to convergent strategies for streamlining the adoption cycle for new technologies as well as the challenges vendors and sponsors face in implementing enterprisewide systems. They also provide a provocative preview of the e-clinical landscape after EDC.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
The Challenges of Pharmacogenomics
Date: 2/1/2007
Length: 00:16:17
Size: 7.45MB
Thought Leader: Brian Spear, Ph.D., Director of Genomic and Proteomic Technologies, Global Pharmaceutical Research and Development — Abbott
Pharmacogenomics is a serious science that has the potential to revolutionize the life sciences. Dr. Spear discusses the myths, misconceptions, trends, and challenges associated with pharmacogenomics and personalized medicine. He also talks about the future of this groundbreaking science.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:16:17
Size: 7.45MB
Thought Leader: Brian Spear, Ph.D., Director of Genomic and Proteomic Technologies, Global Pharmaceutical Research and Development — Abbott
Pharmacogenomics is a serious science that has the potential to revolutionize the life sciences. Dr. Spear discusses the myths, misconceptions, trends, and challenges associated with pharmacogenomics and personalized medicine. He also talks about the future of this groundbreaking science.
Play Full Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Subscribe to:
Posts (Atom)